Amalgamated Bank Cytokinetics Inc Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Cytokinetics Inc stock. As of the latest transaction made, Amalgamated Bank holds 53,622 shares of CYTK stock, worth $2.62 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

53,622

Previous 55,397 3.2%

Holding current value

$2.62 Million

Previous $3 Million 5.66%

% of portfolio

0.02%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	SELL	$51.22 - $60.16 $90,915 - $106,784	-1,775 Reduced 3.2%	53,622 $2.83 Million
Q2 2024 Aug 12, 2024	BUY	$47.86 - $75.05 $196,178 - $307,629	4,099 Added 7.99%	55,397 $3 Million
Q1 2024 Apr 23, 2024	BUY	$63.75 - $108.06 $667,398 - $1.13 Million	10,469 Added 25.64%	51,298 $3.6 Million
Q4 2023 Feb 06, 2024	SELL	$26.88 - $83.49 $27,525 - $85,493	-1,024 Reduced 2.45%	40,829 $3.41 Million
Q3 2023 Nov 08, 2023	SELL	$29.46 - $36.61 $14,995 - $18,634	-509 Reduced 1.2%	41,853 $1.23 Million
Q2 2023 Aug 11, 2023	BUY	$32.62 - $40.75 $28,183 - $35,208	864 Added 2.08%	42,362 $1.38 Million
Q1 2023 May 02, 2023	SELL	$33.36 - $45.71 $81,598 - $111,806	-2,446 Reduced 5.57%	41,498 $1.46 Million
Q4 2022 Feb 10, 2023	BUY	$35.77 - $51.11 $2,968 - $4,242	83 Added 0.19%	43,944 $2.01 Million
Q3 2022 Nov 09, 2022	BUY	$38.54 - $54.52 $133,078 - $188,257	3,453 Added 8.55%	43,861 $2.13 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $16,591 - $23,921	489 Added 1.22%	40,408 $1.59 Million
Q1 2022 Jun 30, 2022	SELL	$29.74 - $46.0 $69,413 - $107,364	-2,334 Reduced 5.52%	39,919 $1.47 Million
Q4 2021 Feb 15, 2022	SELL	$34.35 - $46.38 $5,049 - $6,817	-147 Reduced 0.35%	42,253 $1.93 Million
Q3 2021 Oct 29, 2021	BUY	$18.54 - $35.74 $85,803 - $165,404	4,628 Added 12.25%	42,400 $1.52 Million
Q2 2021 Aug 16, 2021	BUY	$19.79 - $26.99 $557,583 - $760,443	28,175 Added 293.58%	37,772 $748,000
Q1 2021 May 13, 2021	SELL	$18.57 - $25.68 $15,301 - $21,160	-824 Reduced 7.91%	9,597 $223,000
Q4 2020 Feb 12, 2021	BUY	$15.26 - $28.61 $4,425 - $8,296	290 Added 2.86%	10,421 $216,000
Q3 2020 Oct 30, 2020	BUY	$20.58 - $28.96 $23,687 - $33,332	1,151 Added 12.82%	10,131 $219,000
Q2 2020 Aug 10, 2020	SELL	$11.15 - $24.64 $15,264 - $33,732	-1,369 Reduced 13.23%	8,980 $212,000
Q1 2020 May 13, 2020	SELL	$8.75 - $16.3 $3,631 - $6,764	-415 Reduced 3.86%	10,349 $122,000
Q4 2019 Feb 13, 2020	BUY	$7.95 - $11.84 $4,944 - $7,364	622 Added 6.13%	10,764 $114,000
Q3 2019 Nov 13, 2019	SELL	$10.82 - $14.25 $1,265 - $1,667	-117 Reduced 1.14%	10,142 $115,000
Q2 2019 Aug 14, 2019	BUY	$7.95 - $11.25 $81,559 - $115,413	10,259 New	10,259 $115,000

Others Institutions Holding CYTK

# of Institutions

409

Shares Held

125M

Call Options Held

4.6M

Put Options Held

2.43M

View Full List

About CYTOKINETICS INC

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.6B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

More about CYTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Cytokinetics Inc Transaction History